Status:
NOT_YET_RECRUITING
A Safety Assessment of the iZephyr Hood for NIV in COVID-19 Patients
Lead Sponsor:
Imperial College Healthcare NHS Trust
Collaborating Sponsors:
Mercedes AMG PETRONAS Formula One Team
Imperial College London
Conditions:
Aerosol Disease
Covid19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is a safety assessment of the iZephyr hood a novel aerosol removal device in patients receiving non invasive ventilation for COVID-19.
Detailed Description
Demonstrate that safety and suitability of the iZephyr Hood in patients receiving non-invasive ventilation (NIV) or high flow oxygen therapy (HFOT). Determine the user acceptability of the iZephyr Ho...
Eligibility Criteria
Inclusion
- Adult COVID-19 negative patients who are requiring non-invasive ventilation (phase II)
- Adult COVID-19 positive patients who are requiring non-invasive ventilation (Phase III)
Exclusion
- Patients under the age of 18 years or those lacking capacity
Key Trial Info
Start Date :
June 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04904484
Start Date
June 1 2024
End Date
October 1 2025
Last Update
March 13 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.